Alkermes Plc (ALKS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALKS | PTGX | RYTM | ||
| Company | Alkermes Plc | Protagonist Therapeutics Inc | Rhythm Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 36.91 | 102.01 | 89.66 | ||
| High | 37.26 | 102.42 | 90.90 | ||
| Low | 36.58 | 98.89 | 87.75 | ||
| Latest | 36.80 | 99.19 | 87.84 | ||
| Change | -0.15 | -2.82 | -2.35 | ||
| % Change | -0.41% | -2.76% | -2.61% | ||
| Volume | 907,700 | 393,900 | 479,000 | ||
| 20-Day Average Volume | 2,150,220 | 563,920 | 787,135 | ||
| Previous Close | 36.95 | 102.01 | 90.19 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 35.91 | 100.64 | 88.94 | ||
| 20-Day Raw Stochastic | 58.96% | 27.67% | 43.06% | ||
| 20-Day Relative Strength | 58.57 | 48.69 | 48.49 | ||
| Weighted Alpha | +32.48 | +82.57 | +12.64 | ||
| Today's Opinion | 100% Buy | 56% Buy | 56% Sell | ||
| Previous Opinion | 100% Buy | 88% Buy | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.81% since 05/15/26 | -2.93% since 05/15/26 | -2.96% since 05/15/26 | ||
| Low | 36.25 on 05/21/26 | 96.69 on 05/19/26 | 84.90 on 05/19/26 | ||
| High | 38.01 on 05/18/26 | 104.16 on 05/18/26 | 92.13 on 05/21/26 | ||
| 1-Month | |||||
| %Chg | +9.07% since 04/22/26 | -6.03% since 04/22/26 | +3.13% since 04/22/26 | ||
| Low | 32.83 on 04/27/26 | 96.69 on 05/19/26 | 79.40 on 05/01/26 | ||
| High | 39.56 on 05/13/26 | 106.98 on 04/23/26 | 99.00 on 05/05/26 | ||
| 3-Month | |||||
| %Chg | +15.32% since 02/20/26 | +19.85% since 02/20/26 | -11.97% since 02/20/26 | ||
| Low | 27.00 on 03/19/26 | 77.00 on 02/23/26 | 74.50 on 03/30/26 | ||
| High | 39.56 on 05/13/26 | 107.84 on 04/01/26 | 103.25 on 02/26/26 | ||
| 6-Month | |||||
| %Chg | +28.63% since 11/21/25 | +16.15% since 11/21/25 | -13.66% since 11/21/25 | ||
| Low | 27.00 on 03/19/26 | 77.00 on 02/23/26 | 74.50 on 03/30/26 | ||
| High | 39.56 on 05/13/26 | 107.84 on 04/01/26 | 122.20 on 12/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,133,676 | 6,379,008 | 6,019,938 | ||
| Shares Outstanding, K | 166,676 | 64,311 | 68,533 | ||
| Annual Sales | 1,475,900,000 | 46,020,000 | 189,760,000 | ||
| Annual Net Income | 241,660,000 | -130,150,000 | -196,540,000 | ||
| Last Quarter Sales | 392,910,000 | 56,370,000 | 60,110,000 | ||
| Last Quarter Net Income | -66,480,000 | 3,780,000 | -55,640,000 | ||
| 60-Month Beta | 0.31 | 1.89 | 1.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.40 on 05/05/26 | 0.05 on 05/05/26 | -0.83 on 05/05/26 | ||
| Earnings Date | 08/04/26 | 08/05/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 38.89 | 0.00 | 0.00 | ||